Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women.
Explore this paper's citation graph
Summary
In postmenopausal women, important modifications of bone metabolism markers (i.e. RANKL, OPG and OPN) could be due to serious engagement of bone turnover, especially in the pre-osteoporotic phase.
- Type
- article
- Published
- 2006-12-01
- Cited by
- 8
- References
- 0
- OpenAlex
- https://openalex.org/W2417159694
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24038694
Keywords
RANKL, Osteoprotegerin, Bone remodeling, Endocrinology, Internal medicine
References
No references recorded for this paper.
Cited by
- Increased serum osteopontin is a risk factor for osteoporosis in menopausal women
- Quantitative genetic study of the circulating osteopontin in community-selected families
- RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases
- Expression levels of estrogen receptor α mRNA in peripheral blood cells are an independent biomarker for postmenopausal osteoporosis
- OPG/RANK/RANKL AXIS IN PERIODONTOLOGY
- Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
- Gingival crevicular fluid bone turnover biomarkers: How postmenopausal women respond to orthodontic activation
- Pharmacological approaches to sedation in pediatric dentistry: a narrative review
Related papers
- Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor &kgr;B in women with postmenopausal osteoporosis
- Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG/RANKL ratio, as a key regulator of bone metabolism
- Leptin exerts a bone protective effect in ovariectomized rats by inhibiting osteoclastogenesis
- Osteoprotegerin, RANKL, and Bone Turnover in Primary Hyperparathyroidism: The Effect of Parathyroidectomy and Treatment with Alendronate
- Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density
- Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma
- RANKL/RANK/OPG molecular complex--control factors in bone remodeling in psoriatic arthritis.
- Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women
- The RANKL/OPG system and bone mineral density in patients with chronic liver disease.